Skip to main content

Table 4 Distribution of generic prognostic factors at baseline according to good/poor clinical recovery

From: Limited predictive value of illness perceptions for short-term poor recovery in musculoskeletal pain. A multi-center longitudinal study

  Pain intensity recovery Physical Functioning recovery Global Perceived Effect recovery
Good
N = 140
Poor
N = 93
Good
N = 99
Poor
N = 125
Good
N = 54
Poor
N = 180
Pain intensity 0–10 (SD) 6.3 (2.2) 6.3 (2.2) 6.4 (2.0) 6.2 (2.5) 6.4 (2.2) 6.1 (2.4)
Physical functioning (0–10) 6.0 (2.5) 6.1 (2.3) 6.6 (2.0) 6.0 (2.1) 6.4 (2.2) 6.1 (2.2)
Pain duration %
 < 7 weeks 38.7 14.6 40.8 16.9 41.8 18.3
 7–13 weeks 21.0 25.0 17.7 31.0 18.3 29.6
 > 13 weeks 40.3 60.4 41.5 52.1 39.9 52.1
 > 2 pain sites (%) 14.9 35.4 14.3 28.2 15.0 29.6
4DSQ risk of (%)
 Somatization
  Low 64.8 40.4 65.7 51.4 64.0 53.7
  Medium 25.0 46.8 24.5 34.3 27.3 31.3
  High 10.2 12.2 9.8 14.3 8.7 14.9
 Distress
  Low 62.1 53.2 63.6 54.9 62.4 58.6
  Medium 22.6 27.7 23.1 25.4 26.2 20.0
  High 15.3 19.1 13.3 19.7 11.4 21.4
 Anxiety
  Low 76.6 70.8 79.0 68.6 78.5 71.4
  Medium 8.0 16.7 7.7 14.3 10.1 7.1
  High 15.4 12.5 13.3 17.1 11.4 21.4
 Depression
  Low 82.7 81.3 84.2 80.3 85.5 77.5
  Medium 6.7 6.3 6.2 7.0 6.6 7.0
  High 10.6 12.5 9.6 12.7 7.9 15.5
IPs 0–10 (SD)
 Consequences 5.2 (2.8) 6.0 (2.9) 5.3 (2.8) 5.8 (2.9) 5.2 (2.9) 5.7 (2.6)
 Timeline 4.9 (3.3) 6.2 (3.0) 4.7 (3.2) 6.3 (3.2) 4.7 (3.3) 6.4 (3.0)
 Personal Controla 4.9 (2.6) 4.7 (2.2) 4.8 (2.4) 4.7 (2.6) 4.9 (2.6) 4.9 (2.5)
 Treatment Controla 7.5 (1.9) 7.1 (2.4) 7.5 (1.9) 7.0 (3.0) 7.6 (1.9) 6.6 (2.1)
 Identity 5.7 (2.3) 6.3 (2.3) 5.9 (2.2) 6.1 (2.3) 5.2 (2.3) 6.0 (2.3)
 Concern 3.4 (3.0) 4.8 (3.0) 3.9 (2.9) 4.3 (3.1) 3.9 (3.0) 4.6 (3.0)
 Coherencea 7.0 (2.5) 6.6 (2.1) 6.9 (2.6) 7.0 (1.9) 6.9 (2.6) 6.8 (2.1)
 Emotional Response 4.1 (3.0) 5.6 (3.0) 4.0 (3.0) 5.2 (3.0) 4.1 (3.0) 4.9 (2.9)
  1. SD standard deviation, 4DSQ Four-Dimensional Symptom Questionnaire, IP illness perception. a Scoring reversed